In practice: RECOVERY Trial
The Randomised Evaluation of coronavirus disease 2019 (COVID-19) Therapy Trial (RECOVERY) has been the largest COVID-19 treatment study conducted. It provided compelling evidence on the safety and efficacy, or lack thereof, of a multitude of therapies postulated to be of benefit to COVID-19 patients...
Hauptverfasser: | Horby, P, Peto, L, Landray, M |
---|---|
Weitere Verfasser: | Sorenson, RA |
Format: | Book section |
Sprache: | English |
Veröffentlicht: |
Springer
2024
|
Ähnliche Einträge
Ähnliche Einträge
-
Establishing COVID-19 trials at scale and pace: experience from the RECOVERY trial
von: Peto, L, et al.
Veröffentlicht: (2022) -
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial – authors' reply
von: Peto, L, et al.
Veröffentlicht: (2024) -
Making trials part of good clinical care: lessons from the RECOVERY trial
von: Pessoa-Amorim, G, et al.
Veröffentlicht: (2021) -
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
von: Mafham, M, et al.
Veröffentlicht: (2021) -
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
von: Landray, M, et al.
Veröffentlicht: (2022)